Company news
Genovis AB news in 2025
Genovis AB's news releases, calls and decks from 2025, newest first.
Genovis AB Interim report January-September 2025
November 7, 2025
Genovis receives order worth approximately 1 million euros from global pharmaceutical company
October 17, 2025
Genovis AB Half-Yearly report January – June 2025
August 12, 2025
Genovis Expands License Agreement to Access Proprietary Enzyme Technology for Therapeutic Antibody-Drug Conjugate Development
July 24, 2025
Genovis Exercises Call Option to Acquire Remaining Shares in SEQURNA, a fast-growing next-generation RNase inhibitors company
July 1, 2025